Literature DB >> 8056772

Three different cDNAs encoding mouse D-factor/LIF receptor.

M Tomida1, Y Yamamoto-Yamaguchi, M Hozumi.   

Abstract

Three cDNAs for mouse differentiation-stimulating factor (D-factor)/leukemia inhibitory factor (LIF) receptor were isolated from a cDNA library prepared from the liver of a pregnant mouse. A probe for screening was prepared by the RT-PCR method using human cDNA sequences as primers. The mouse D-factor receptor cDNA encoded 1,092 amino acids, which had a marked homology with the human counterpart and consisted of signal sequence, extracellular, transmembrane, and cytoplasmic domains. The WSXWS motif found in members of the cytokine receptor family was also present in the extracellular domain of the mouse D-factor receptor. A second form of cDNA that had a 501 bp insertion was isolated. The insertion introduced a stop codon so that the mRNA encoded the soluble receptor lacking transmembrane and intracellular domains. Because the insertion contained polyadenylation signals, two different sizes of mRNA encoding the soluble receptor were produced, depending on whether or not it utilized these signals. Transcripts utilizing these signals were 2.6-3 kb in size, and were very abundantly expressed in the liver. Transcripts that did not use these signals were longer than 5 kb and of similar size to the mRNA for the cellular receptor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8056772     DOI: 10.1093/oxfordjournals.jbchem.a124375

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  9 in total

Review 1.  Receptor recognition by gp130 cytokines.

Authors:  J Bravo; J K Heath
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  Expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha, and gp130) in human peripheral neuropathies.

Authors:  Y Ito; M Yamamoto; N Mitsuma; M Li; N Hattori; G Sobue
Journal:  Neurochem Res       Date:  2001-01       Impact factor: 3.996

3.  Comparative time-dependent analysis of potential inflammation biomarkers in lymphoma-bearing SJL mice.

Authors:  Monica H Kristiansson; Vadiraja B Bhat; I Ramesh Babu; John S Wishnok; Steven R Tannenbaum
Journal:  J Proteome Res       Date:  2007-03-28       Impact factor: 4.466

4.  Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation.

Authors:  J G Cheng; J R Chen; L Hernandez; W G Alvord; C L Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 5.  The role of the leukemia inhibitory factor receptor in neuroprotective signaling.

Authors:  Stephanie M Davis; Keith R Pennypacker
Journal:  Pharmacol Ther       Date:  2017-08-19       Impact factor: 12.310

6.  Recent evolutionary acquisition of alternative pre-mRNA splicing and 3' processing regulations induced by intronic B2 SINE insertion.

Authors:  D Michel; G Chatelain; C Mauduit; M Benahmed; G Brun
Journal:  Nucleic Acids Res       Date:  1997-08-15       Impact factor: 16.971

7.  Structure of the mouse leukaemia inhibitory factor receptor gene: regulated expression of mRNA encoding a soluble receptor isoform from an alternative 5' untranslated region.

Authors:  I Chambers; A Cozens; J Broadbent; M Robertson; M Lee; M Li; A Smith
Journal:  Biochem J       Date:  1997-12-15       Impact factor: 3.857

8.  RNF41 (Nrdp1) controls type 1 cytokine receptor degradation and ectodomain shedding.

Authors:  Joris Wauman; Leentje De Ceuninck; Nele Vanderroost; Sam Lievens; Jan Tavernier
Journal:  J Cell Sci       Date:  2011-03-15       Impact factor: 5.285

9.  Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation.

Authors:  M Ernst; M Inglese; P Waring; I K Campbell; S Bao; F J Clay; W S Alexander; I P Wicks; D M Tarlinton; U Novak; J K Heath; A R Dunn
Journal:  J Exp Med       Date:  2001-07-16       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.